How much funding has Arine raised?

Arine has raised $70.0M in total funding, most recently a Series C round.

Who are Arine's investors?

Arine's investors include Town Hall Ventures, 111° West Capital, Kaiser Permanente Ventures.

Where is Arine headquartered?

Arine is headquartered in San Francisco, California, United States.

What industry is Arine in?

Arine operates in Artificial Intelligence, Healthcare.

Arine

Enlightening Care Delivery Through Medications

San Francisco, United States · Founded 2017 · $70.0M raised

Artificial Intelligence

Healthcare

Headquarters: San Francisco, California
Employees: 201–500
Founded: 2017
Business Model: B2B

Website: arine.io
Total Funding: $70.0M
Last Round: $30.0M Series CJun 2025
Rounds: 3

About

Arine is an AI-driven medication management platform that combines advanced data science with clinical expertise to help health plans and providers identify and address medication-related problems at scale. Founded in 2017, the company offers a suite of solutions — including LUMINATE for high-risk member management, RESONATE for prescriber analytics, and ELEVATE for quality improvement — that enable clinicians to deliver personalized, proactive medication care across large member populations. Arine platform has positively impacted over 30 million lives, produced more than 40 million life-enhancing recommendations annually, and partners with more than 30 health plans including five leading national plans and seven Blue Cross Blue Shield plans.

Summary

Arine is an Artificial Intelligence company based in San Francisco, United States, founded in 2017. It has raised $70.0M in total across 3 rounds, most recently a $30.0M Series C round in Jun 2025. Investors include Town Hall Ventures, 111° West Capital and Kaiser Permanente Ventures.